Kathrine Gamborg Andreassen

Kathrine Gamborg Andreassen is an experienced executive in the health and pharmaceutical industries, currently serving as CEO and Chair of the Board at Navamedic ASA since June 2018. Additionally, Kathrine holds board member positions at Observe Medical and is an industry expert at Infima. Previously, Kathrine founded and chaired Novicus Pharma AS, focusing on OTC and OTX products for the Nordic market, and led Weifa AS as CEO, developing a range of medicinal products and supplements. Further experience includes roles as VP of Consumer Health at Vistin Pharma AS and Group Marketing and Communications Director at Kemetyl Group. Educationally, Kathrine holds a Master of Science in business from the University of Wisconsin-Madison and a Bachelor of Business Administration in International Marketing from Handelsakademiet.